Market closedRefreshes 15sData NSENot investment advice
Uniphos Enterprises

Uniphos Enterprises Share Price Today (UNIENTER)

NSE: UNIENTERBSE 500429ChemicalsTrading - Chemicalswww.uelonline.com
TechnicalsTV Chart
108.69
1.86−1.68%
DAY107
₹108.69
114
52W88
₹108.69
169
Open113.50
Prev Close110.55
Bid108.66100
Ask108.72100

Today’s Uniphos Stock Read

Uniphos Enterprises is trading down 1.68% at ₹108.69. With a market cap of ₹765 Cr, it trades at a P/E of 36.91. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume3.8K21%vs 20D avg
Market Cap₹765 Cr
Promoter Hold.73.78%
Face Value₹2
Fwd P/E
PEG
EV/EBITDA28.83
P/S23.62
ROA-0.1%
Beta0.98
Div Payout16.78%
Valuation

Uniphos Enterprises Limited valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Uniphos Enterprises Limited, framed against the sector median so the premium or discount is obvious at a glance.

Uniphos Enterprises Limited trades at a P/E of 36.91× and P/B of 0.31×.

Key MetricsLive · as of 25 Jun 2026
the price tag

Valuation

Market Cap
₹765 Cr
P/E Ratio
avg36.91
P/B Ratio
good0.31
EPS
2.98
the engine

Profitability

ROE
watch0.8%
ROCE
watch0.8%
Net Margin
good64.72%
Op Margin
watch-3.8%
the trajectory

Growth

EPS YoY
%
Revenue YoY
watch-64.1%
Qtr Sales
watch-64.1%
Qtr Profit
good55.7%
the balance sheet

Financial Health

Debt / Equity
Book Value
348.1
Div Yield
avg0.46%
Promoter Hold.
good73.78%
Chart Patterns

Uniphos Enterprises Limited chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for Uniphos Enterprises Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Financials

Uniphos Enterprises Limited financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Uniphos Enterprises Limited, switchable between annual and quarterly views, consolidated or standalone.

Uniphos Enterprises Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹765 Cr and reported EPS of ₹2.98.

all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Uniphos Enterprises segment analysis: revenue and profit mix.

Disclosed business segments at Uniphos Enterprises with their share of revenue and profit, switchable between consolidated and standalone reporting.

Uniphos Enterprises discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for Uniphos Enterprises Limited.

Our AI distills the core fundamental drivers supporting Uniphos Enterprises Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.

Uniphos Enterprises Limited's investment case rests on 9 positive markers and 9 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • Promoter holding is robust at 73.8%, indicating strong management confidence.

  • Zero debt-to-equity ratio (0.00) provides significant financial stability.

  • Stock trades below book value (0.39 P/B), potentially indicating an undervalued asset.

  • Substantial quarterly sales growth of 93.40% signals positive revenue momentum.

  • Increasing FII holding (15.71%) suggests growing external investor interest.

bear case

What can break it.

  • Reported negative quarterly profit after tax of -0.74 Cr.

  • Extremely low ROCE (0.06%) and ROE (0.01%) indicate poor capital returns.

  • Quarterly profit after tax declined drastically by -393.00%.

  • Negative EPS (-0.0382) reflects unprofitable operations, unattractive for investors.

  • Negative operating profit margin (-4.05%) highlights significant operational inefficiencies.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 48. The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.

  • Income thesis breaks if the dividend is cut or yield falls below 0.23%.

Shareholding

Uniphos shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Uniphos — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Uniphos Enterprises Limited peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Uniphos Enterprises Limited is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
Uniphos Enterprises Limited
₹765 Cr
Best Profit Growth
Uniphos Enterprises Limited
55.70 %
Highest Dividend Yield
Vinyl Chemicals (India) Limited
5.45 %
Technicals

Uniphos Enterprises Limited technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Uniphos Enterprises Limited — derived from the live tape, not yesterday's close.

Uniphos Enterprises Limited last traded at ₹108.69 with an intraday range of ₹107–₹113.5 — live indicator, pivot and CPR signals below.

Last Updated at :

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹108.69
LevelPrice (₹)Distance% Δ
R4125.46+16.77+15.43%
R3118.96+10.27+9.45%
R2116.23+7.54+6.94%
R1112.46+3.77+3.47%
PIVOT109.731.040.96%
CURRENT108.69
S192.96-15.73-14.47%
S299.46-9.23-8.49%
S3103.23-5.46-5.02%
S4105.96-2.73-2.51%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 109.21P: 109.73TC: 110.25
R1
R2
R3
R4
indicator
LTP: 108.69
PDH: 111.70
PDL: 108.51
● Market Sentiment

UNIENTER is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: 107 ~ 113.5

● Price Position

Trading Inside opening range

Delivery & Volume

Uniphos Enterprises Limited delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Uniphos Enterprises Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Uniphos Enterprises Limited stood at 49.7% of traded volume, against a 20-day average of 63.1%.

Avg Delivery (20D)63.1%-13.4 ppt latest vs avg
Highest Delivery90.7%on 04 Jun
Avg Volume (20D)4.7 K20-day run-rate
Conviction Trend↓ Weakening-13.4 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Uniphos Enterprises announcements: results, concalls, ratings, M&A.

Filings Uniphos Enterprises sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Uniphos Enterprises files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 25 documents below.

  1. 29 May 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    Uniphos Enterprises Limited has informed the Exchange about Copy of Newspaper Publication

  2. 15 Apr 2026Certificate under SEBI (Depositories and Participants) Regulations, 2018View PDF

    Certificate under SEBI (Depositories and Participants) Regulations, 2018

    Uniphos Enterprises Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  3. 09 Apr 2026Disclosure under SEBI Takeover RegulationsView PDF

    Disclosure under SEBI Takeover Regulations

    Nerka Chemicals Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…

  4. 31 Mar 2026Trading WindowView PDF

    Trading Window

    Uniphos Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…

  5. 07 Feb 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    Uniphos Enterprises Limited has informed the Exchange about Copy of Newspaper Publication

Corporate Actions

Uniphos Enterprises dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Uniphos Enterprises has declared, sequenced by announce and record date.

Uniphos Enterprises corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Uniphos Enterprises Limited: business, sector, key facts.

What Uniphos Enterprises Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Uniphos Enterprises Limited operates in the Trading - Chemicals industry under the Chemicals sector, listed as NSE: UNIENTER, BSE: 500429.

UNIENTER
Chemicals

Uniphos Enterprises Limited

NSE · UNIENTER·BSE · 500429·www.uelonline.com

Uniphos Enterprises Limited (UEL) is an Indian company primarily involved in the trading of chemicals and other products within the domestic market. This forms a core component of its business operations, encompassing the sourcing, distribution, and sale of a diverse range of chemical commodities. The specifics of these chemical products and their applications are not detailed in the provided information, but it's clear that chemical trading represents a significant aspect of UEL's revenue generation.

Beyond its chemical trading activities, UEL also participates in the investment sector. The company engages in investments in both listed (quoted) and unlisted (unquoted) securities. This diversification suggests a strategy aimed at balancing risk and potentially generating additional returns beyond the trading arm of the business. The nature and scale of these investments – whether in stocks, bonds, or other securities – remain unspecified in the provided context.

Established in 1969 and headquartered in Mumbai, India, UEL boasts a relatively long history in the Indian business landscape. This suggests a degree of established market presence and potentially strong relationships within the chemical and investment communities. The company's longevity might also indicate a resilient business model capable of adapting to evolving market conditions over several decades.

It's important to note that UEL operates as a subsidiary of Nerka Chemicals Private Limited. This organizational structure indicates that UEL's strategic direction and operational decisions are ultimately influenced by its parent company. The nature of the relationship between Nerka Chemicals and UEL, and the extent to which Nerka Chemicals provides resources or direction, are not detailed in the available information.

In summary, Uniphos Enterprises Limited functions as a multifaceted company operating within the chemical trading and investment sectors in India. Its long operational history and subsidiary status within a larger chemical entity provide context for understanding its position and activities within the Indian market. However, the specifics of its product range, investment portfolio, and the exact nature of its relationship with its parent company are not fully elaborated upon in the source material.

company facts
Employees
SectorChemicals
HeadquartersMumbai, India
Market Cap₹765 Cr
Listed OnNSE
leadership14 on record
Mr. Amit Jain
Company Secretary & Compliance Officer
Mr. Arun Ashar
Non-Executive Chairman of the Board
Mr. Bipin Chheda
Chief Financial Officer
Mr. Bipin Premji Chheda
Chief Financial Officer
Mr. Jaidev Shroff
Non-Executive Director
Mr. Kanti Mangalji Thacker
Compliance Officer & Company Secretary
Mr. K. R. Srivastava B.Chem, DSM, PGDBMA(IIM)
Chief Operating Officer
Mr. K. Thacker
Compliance Officer, Company Secretary
Mr. Prasad Paranjape
Additional Non-Executive Independent Director
Mr. Rajnikant Shroff
Managing Director
Mrs. Meena Ved
Additional Non-Executive Independent Director
Mrs. Sandra Shroff
Non-Executive Vice Chairman of the Board
§ ∞ · Plainly Answered

Questions investors ask about Uniphos Enterprises Limited (UNIENTER).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Uniphos Enterprises Limited (UNIENTER)?

The current share price of Uniphos Enterprises Limited (UNIENTER) is ₹108.69. Today, the stock has declined by ₹1.86 (1.68%), trading in a range of ₹107 to ₹113.5. The stock opened at ₹113.5 with a trading volume of 3,755 shares.

02Is Uniphos Enterprises Limited stock a good investment for long-term?

Uniphos Enterprises Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹765 crores, P/E ratio of 36.91, ROE of 0.80%, and ROCE of 0.80%. The dividend yield stands at 0.46%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Uniphos Enterprises Limited stock?

The 52-week high price of Uniphos Enterprises Limited (UNIENTER) is ₹168.5, while the 52-week low is ₹87.51. Currently trading at ₹108.69, the stock is 26.2% away from its 52-week low and 35.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Uniphos Enterprises Limited stock at the current price?

Whether to buy Uniphos Enterprises Limited stock at ₹108.69 depends on multiple factors. The stock is currently trading with a P/E ratio of 36.91 and P/B ratio of 0.31. Today's performance shows a loss of 1.68%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Uniphos Enterprises Limited and when is the next dividend?

Uniphos Enterprises Limited offers a dividend yield of 0.46%, which means for every ₹100 invested at the current price of ₹108.69, you can expect to receive approximately ₹0.46 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Uniphos Enterprises Limited?

Uniphos Enterprises Limited's key financial metrics include: P/E Ratio: 36.91, P/B Ratio: 0.31, ROE: 0.80%, ROCE: 0.80%, Dividend Yield: 0.46%, EPS: ₹2.98, Book Value: ₹348.1, and Debt-to-Equity: 0.00. The company's market cap stands at ₹765 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Uniphos Enterprises Limited stock performing today in the market?

Uniphos Enterprises Limited stock opened at ₹113.5 and is currently trading at ₹108.69, showing a decline of ₹1.86 (1.68%). The intraday high is ₹113.5 and low is ₹107. The trading volume stands at 3,755 shares, indicating moderate market participation today.

08What is the P/E ratio of Uniphos Enterprises Limited and what does it indicate?

Uniphos Enterprises Limited has a Price-to-Earnings (P/E) ratio of 36.91, which means investors are willing to pay ₹36.91 for every ₹1 of earnings. With an EPS of ₹2.98, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Uniphos Enterprises Limited (UNIENTER) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.